Prospective SPIRIT-HCM trial demonstrates broad gains over 12-month follow-up
First report of major endpoint reduction in patients with biopsy-proven NASH
TMAO pathway impacts infarct size and functional impairment in preclinical stroke models
Cleveland Clinic-led study supports investigation of similar immunomodulatory therapies
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Review of our recent experience shows it’s still a safe option
Machine learning may improve risk prediction and guide therapy
High-dose omega-3 fatty acid conferred no outcomes benefit over corn oil in high-risk patients
Phase 3 study may lead to first FDA approval for the indication
Analysis used echocardiographic data to assess structural valve deterioration
Results achieved despite increased complexity and venous occlusive disease
Advertisement
Advertisement